Trade AQST anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Aquestive Therapeutics, Inc. (AQST) is trading at US$5.34, down 0.19% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$584.88M. Over the past 52 weeks, AQST has traded between US$2.93 and US$7.55. On Syfe you can trade AQST with $0 commission and add it to your watchlist.
| Previous close | US$5.35 |
|---|---|
| Market cap | US$584.88M |
| 52-week range | US$2.93 – US$7.55 |
| Volume | 2.12M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Year: 2018
Aquestive Therapeutics Signs New $150 Million Debt Facility
May 12, 2:41 PM · MT Newswires
Aquestive Therapeutics Receives FDA's Preliminary Comments on Anaphylm Study Designs
Mar 30, 12:08 PM · MT Newswires
Aquestive Therapeutics, Inc. (AQST) stock is trading at US$5.34, -0.19% from the previous close of US$5.35.
The market cap for Aquestive Therapeutics, Inc. (AQST) stock is approximately US$584.88M.
The 52-week high for Aquestive Therapeutics, Inc. (AQST) stock is US$7.55.
The 52-week low for Aquestive Therapeutics, Inc. (AQST) stock is US$2.93.
Aquestive Therapeutics, Inc. (AQST) does not currently pay a dividend.
Stay on top of AQST
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
